David Henry Mack, President and CEO at PMV Pharmaceuticals, Inc. (PMVP), sold 204 shares at $35.53 ($7K) on 2021-06-28, disclosed to the SEC on 2021-06-29.
Scheduled sale ($7k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PMVP | SELL | 2021-05-24 | $998K | — | Filing → |
| ACRX | BUY | 2011-02-18 | $3.4M | — | Filing → |